In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Device Therapy in Heart Failure (Focused Update)

ESC Clinical Practice Guidelines

The current heart failure (HF) guidelines were published in 2008 and the cardiac pacing guidelines in 2007.  In order to keep these guidelines up to date, it would be appropriate to modify the recommendations and levels of evidence according to the most recent clinical trial evidence.
This Focused Update on the use of devices in heart failure 2010 is the first publication of its kind from the CPG.  In contrast to previous guidelines, this focused update considers the characteristics of the patients included in the trials and contains several examples.

Cardiovascular Surgery
Device Therapy
Cardiac Resynchronization Therapy
Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
Chronic Heart Failure
Implantable Cardioverter \ Defibrillator
Heart Failure
Guidelines version available to download
Published in 2010
Reference European Heart Journal (2010) 31, 2677–2687; doi:10.1093/eurheartj/ehq337
Published in 2010
Reference Pocket Guidelines CRT-HF
Table of contents: Full Text (ESC Clinical Practice Guidelines)
  1. Introduction
  2. Cardiac resynchronisation therapy with pacemaker/defibrillator function in patients with heart failure in NYHA function class III/IV
  3. Cardiac resynchronisaiton therapy with defibrillator function in patients with heart failure in NYHA funciton class I/III
  4. Cardiac resynchronisation ttherapy with pacemaker/defibrillator function in patients with heart failure and permanent atrial fibrillation
  5. Cardiac resynchronisation therapy with pacemaker/defibrillator function in patients with heart failure ad a conventional pacemaker indication
  6. Left ventricular assist device as destination therapy for patients with severe heart failure ineligible for cardiac transplantation
  7. Evidence tables
  8. References